Results 311 to 320 of about 94,238 (337)
Some of the next articles are maybe not open access.

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Michael L Cheng   +2 more
exaly  

Cancer statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Rebecca L Siegel   +2 more
exaly  

Advanced Glycation End Products in Neurodegenerative Diseases

Journal of Molecular Neuroscience
Advanced glycation end products (AGEs) have attracted interest as therapeutic targets for neurodegenerative diseases. AGEs facilitate the onset and progression of various neurogenerative disorders due to their ability to promote cross-linking and aggregation of proteins.
openaire   +2 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel   +2 more
exaly  

Hemodialysis Techniques and Advanced Glycation End Products

2000
TESSITORE N.   +5 more
openaire   +4 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Artificial intelligence in cancer imaging: Clinical challenges and applications

Ca-A Cancer Journal for Clinicians, 2019
Wenya Linda Bi   +2 more
exaly  

Nutrition and physical activity guidelines for cancer survivors

Ca-A Cancer Journal for Clinicians, 2012
Cheryl L Rock   +2 more
exaly  

Home - About - Disclaimer - Privacy